BamSEC and AlphaSense Join Forces
Learn More

Vistagen Therapeutics Inc.

NASDAQ: VTGN    
Share price (1/6/25): $3.20    
Market cap (1/6/25): $89.1 million
Search in Documents
Key Exhibits
External Links

Transcripts

CY 2024
Earnings Revised 11/07/24 Vistagen Therapeutics, Inc., Q2 2025 Earnings Call, Nov 07, 2024 11/07/24 Earnings Revised 08/13/24 Vistagen Therapeutics, Inc., Q1 2025 Earnings Call, Aug 13, 2024 08/13/24 Earnings Revised 06/11/24 Vistagen Therapeutics, Inc., Q4 2024 Earnings Call, Jun 11, 2024 06/11/24 Earnings Revised 02/13/24 Vistagen Therapeutics, Inc., Q3 2024 Earnings Call, Feb 13, 2024 02/13/24
CY 2023
Earnings Revised 11/27/23 Vistagen Therapeutics, Inc., Q2 2024 Earnings Call, Nov 09, 2023 11/09/23 Earnings Revised 08/11/23 Vistagen Therapeutics, Inc., Q1 2024 Earnings Call, Aug 10, 2023 08/10/23 Earnings Revised 06/28/23 Vistagen Therapeutics, Inc., 2023 Earnings Call, Jun 28, 2023 06/28/23 Earnings Revised 02/07/23 VistaGen Therapeutics, Inc., Q3 2023 Earnings Call, Feb 07, 2023 02/07/23
CY 2022
Earnings Revised 11/10/22 VistaGen Therapeutics, Inc., Q2 2023 Earnings Call, Nov 10, 2022 11/10/22 Other Revised 05/16/24 VistaGen Therapeutics, Inc. Presents at Morgan Stanley 20th Annual Global Healthcare Conference, Sep-13-2022 11:45 AM 09/13/22 Earnings Revised 08/11/22 VistaGen Therapeutics, Inc., Q1 2023 Earnings Call, Aug 11, 2022 08/11/22 Earnings Revised 06/23/22 VistaGen Therapeutics, Inc., 2022 Earnings Call, Jun 23, 2022 06/23/22 Earnings Revised 02/10/22 VistaGen Therapeutics, Inc., Q3 2022 Earnings Call, Feb 10, 2022 02/10/22